Blackhawk Capital Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.87M | Buy |
11,393
+600
| +6% | +$129K | 0.94% | 31 |
|
|
2026
Q1 | $2.35M | Sell |
10,793
-118
| -1% | -$26.2K | 0.86% | 28 |
|
|
2025
Q4 | $2.49M | Sell |
10,911
-187
| -2% | -$42.6K | 0.94% | 28 |
|
|
2025
Q3 | $2.57M | Sell |
11,098
-100
| -0.9% | -$20.4K | 1% | 29 |
|
|
2025
Q2 | $2.08M | Buy |
11,198
+5
| +0% | +$929 | 0.96% | 33 |
|
|
2025
Q1 | $2.35M | Sell |
11,193
-81
| -0.7% | -$15.7K | 1.21% | 25 |
|
|
2024
Q4 | $2M | Hold |
11,274
| – | – | 1.04% | 30 |
|
|
2024
Q3 | $2.23M | Hold |
11,274
| – | – | 1.19% | 27 |
|
|
2024
Q2 | $1.93M | Hold |
11,274
| – | – | 1.17% | 27 |
|
|
2024
Q1 | $2.05M | Sell |
11,274
-60
| -0.5% | -$10.3K | 1.28% | 27 |
|
|
2023
Q4 | $1.76M | Hold |
11,334
| – | – | 1.19% | 32 |
|
|
2023
Q3 | $1.69M | Hold |
11,334
| – | – | 1.24% | 32 |
|
|
2023
Q2 | $1.53M | Hold |
11,334
| – | – | 1.06% | 39 |
|
|
2023
Q1 | $1.81M | Sell |
11,334
-114
| -1% | -$17.4K | 1.32% | 29 |
|
|
2022
Q4 | $1.85M | Sell |
11,448
-2,175
| -16% | -$333K | 1.45% | 24 |
|
|
2022
Q3 | $1.83M | Hold |
13,623
| – | – | 1.51% | 20 |
|
|
2022
Q2 | $2.09M | Buy |
13,623
+9,223
| +210% | +$1.41M | 1.63% | 20 |
|
|
2022
Q1 | $713K | Sell |
4,400
-18,109
| -80% | -$2.63M | 0.48% | 64 |
|
|
2021
Q4 | $3.05M | Buy |
22,509
+463
| +2% | +$54.7K | 1.84% | 14 |
|
|
2021
Q3 | $2.38M | Buy |
22,046
+2,839
| +15% | +$324K | 1.5% | 17 |
|
|
2021
Q2 | $2.08M | Buy |
19,207
+467
| +2% | +$52.6K | 1.41% | 22 |
|
|
2021
Q1 | $2.01M | Sell |
18,740
-29
| -0.2% | -$3.1K | 1.51% | 17 |
|
|
2020
Q4 | $1.64M | Buy |
18,769
+1,031
| +6% | +$99.1K | 1.41% | 24 |
|
|
2020
Q3 | $1.74M | Sell |
17,738
-7,318
| -29% | -$689K | 1.58% | 20 |
|
|
2020
Q2 | $1.91M | Sell |
25,056
-1,739
| -6% | -$153K | 2.28% | 13 |
|
|
2020
Q1 | $2.37M | Sell |
26,795
-2,804
| -9% | -$239K | 2.12% | 15 |
|
|
2019
Q4 | $2.24M | Hold |
29,599
| – | – | 2.23% | 10 |
|
|
2019
Q3 | $2.24M | Buy |
29,599
+3,295
| +13% | +$226K | 2.1% | 11 |
|
|
2019
Q2 | $1.91M | Buy |
26,304
+5,554
| +27% | +$437K | 1.83% | 19 |
|
|
2019
Q1 | $1.67M | Buy |
20,750
+8,823
| +74% | +$722K | 1.73% | 18 |
|
|
2018
Q4 | $1.1M | Buy |
11,927
+8,229
| +223% | +$724K | 1.4% | 32 |
|
|
2018
Q3 | $350K | Hold |
3,698
| – | – | 0.49% | 47 |
|
|
2018
Q2 | $343K | Buy |
3,698
+149
| +4% | +$14.6K | 0.39% | 67 |
|
|
2018
Q1 | $336K | Sell |
3,549
-357
| -9% | -$39.2K | 0.29% | 73 |
|
|
2017
Q4 | $378K | Buy |
+3,906
| New | +$368K | 0.33% | 73 |
|
Other funds holding ABBV
ATO
HCM
AAMU
FWCM
AAIS
Blackhawk Capital Partners's ABBV Position: Q2 2026 in Review
Blackhawk Capital Partners increased its AbbVie (ABBV) stake by 5.6% in Q2 2026, buying an estimated $129K and bringing the position to 11,393 shares worth $2.87M. The position accounts for 0.94% of the portfolio, ranked #31.
Blackhawk Capital Partners first reported a position in ABBV in Q4 2017 and has held it in 35 quarters since. The position peaked at $3.05M in Q4 2021. 1,503 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Blackhawk Capital Partners held 11,393 shares of AbbVie worth $2.87M as of Q2 2026.
- Blackhawk Capital Partners bought 600 AbbVie shares in Q2 2026, an estimated $129K.
- AbbVie made up 0.94% of Blackhawk Capital Partners's portfolio in Q2 2026, its #31 holding.
- Blackhawk Capital Partners first reported a position in AbbVie in Q4 2017 and has held it in 35 quarters since.
- Blackhawk Capital Partners's AbbVie position peaked at $3.05M in Q4 2021.
- 1,503 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Blackhawk Capital Partners's 13F filing for Q2 2026, filed 20 Jul 2026.